| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |